Mass-Spectrometry-Based Functional Proteomic and Phosphoproteomic Technologies and Their Application for Analyzing Ex Vivo and In Vitro Models of Hypertrophic Cardiomyopathy
Moore, J.; Emili, A. Mass-Spectrometry-Based Functional Proteomic and Phosphoproteomic Technologies and Their Application for Analyzing Ex Vivo and In Vitro Models of Hypertrophic Cardiomyopathy. Int. J. Mol. Sci. 2021, 22, 13644. https://doi.org/10.3390/ijms222413644
Moore J, Emili A. Mass-Spectrometry-Based Functional Proteomic and Phosphoproteomic Technologies and Their Application for Analyzing Ex Vivo and In Vitro Models of Hypertrophic Cardiomyopathy. International Journal of Molecular Sciences. 2021; 22(24):13644. https://doi.org/10.3390/ijms222413644
Chicago/Turabian StyleMoore, Jarrod, and Andrew Emili. 2021. "Mass-Spectrometry-Based Functional Proteomic and Phosphoproteomic Technologies and Their Application for Analyzing Ex Vivo and In Vitro Models of Hypertrophic Cardiomyopathy" International Journal of Molecular Sciences 22, no. 24: 13644. https://doi.org/10.3390/ijms222413644